Proteovec Holding LLC
Records under this name other than patents Proteovec Holding LLC holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 9,150,880 | Novel Vectors for Production of Antibodies now held by Proteovec Holding, L.L.C. Term ended Term ended Jun 26, 2023 · Medium confidence | Term ended | Term ended Jun 26, 2023 | Medium confidence |
| US 9,150,881 | Production of Proteins Using Transposon-Based Vectors now held by Proteovec Holding, L.L.C. Term ended Term ended Jun 26, 2023 · Medium confidence | Term ended | Term ended Jun 26, 2023 | Medium confidence |
| US 9,157,097 | Novel Vectors for Production of Growth Hormone now held by Proteovec Holding, L.L.C. Term ended Term ended Jun 26, 2023 · Medium confidence | Term ended | Term ended Jun 26, 2023 | Medium confidence |
| US 7,527,966 | Gene Regulation in Transgenic Animals Using a Transposon-Based Vector now held by Proteovec Holding, L.L.C. Lapsed on the fee record Ended May 5, 2021 · High confidence | Lapsed on the fee record | Ended May 5, 2021 | High confidence |
| US 8,283,518 | Administration of Transposon-Based Vectors to Reproductive Organs now held by Proteovec Holding, L.L.C. Lapsed on the fee record Ended Oct 9, 2020 · Medium confidence | Lapsed on the fee record | Ended Oct 9, 2020 | Medium confidence |
| US 8,236,294 | Gene Therapy Using Transposon-Based Vectors now held by Proteovec Holding, L.L.C. Lapsed on the fee record Ended Aug 7, 2020 · High confidence | Lapsed on the fee record | Ended Aug 7, 2020 | High confidence |
| US 7,608,451 | Gene Regulation in Transgenic Animals Using a Transposon-Based Vector now held by Proteovec Holding, L.L.C. Lapsed on the fee record Ended Oct 27, 2017 · Medium confidence | Lapsed on the fee record | Ended Oct 27, 2017 | Medium confidence |
| US 8,071,364 | Gene Therapy Using Transposon-Based Vectors now held by Proteovec Holding, L.L.C. Lapsed on the fee record Ended Dec 6, 2015 · High confidence | Lapsed on the fee record | Ended Dec 6, 2015 | High confidence |
| 10/746,149 | Administration of transposon-based vectors to reproductive organs now held by Board of Supervisors of Louisiana State University and Agricultural and Mechanical College The Abandoned Abandoned | Abandoned | Abandoned | |
| 10/746,943 | Production of multimeric proteins now held by Board of Supervisors of Louisiana State University and Agricultural and Mechanical College The Abandoned Abandoned | Abandoned | Abandoned |